举报
2003-12-16 15:10
呵呵。我帮你找到了。写的不错!
Curr Opin Immunol. 2000 Oct;12(5):576-82. Design and evaluation of antigen-specific vaccination strategies against cancer. Offringa R, van der Burg SH, Ossendorp F, Toes RE, Melief CJ. Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, The Netherlands. Offringa@mail.MedFac.LeidenUniv.nl After studies in preclinical mouse models, the efficacy and safety of tumor-specific vaccination strategies is currently being evaluated in cancer patients. The first wave of clinical trials has shown that in general such vaccination strategies are safe. However examples of clinical responses, especially in conjunction with vaccine-induced immune responses, are still scarce. The fact that most trials have so far been performed with end-stage cancer patients can largely account for this deficit. Greater efficacy of anticancer vaccines is expected in patients with less-progressed disease. In addition, the detection of both natural and vaccine-induced T cell immunity needs further improvement. Publication Types: Review Review, Tutorial |
举报
2003-12-17 09:09
请结合阅读:
...... |
举报
2003-12-22 06:56
真的吗
|
举报
2003-12-20 10:34
认真学习
|
举报
2003-12-21 07:48
人体有很多未知啊,自身免疫研究好了,也可能肿瘤等疾病就攻克了!
|
举报
2003-12-15 12:39
科学就是在自相矛盾中进步的!免疫学是一门新兴学科,具有较好的发展前途!希望大家多关注!
|